GlassScriptPhysician profile
Jonathan E Bernie
NPI 1548352636
$4,098.63
in general payments reported to CMS, 2019-2025
38 companies · $687 in 2025
The $687 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786 · 2020: $205 · 2021: $495 · 2022: $632 · 2023: $542 · 2024: $752 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,980.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $681.91 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $496.22 | 2019-2025 | Xtandi |
| 180 Medical, INC. | $283.17 | 2019-2025 | |
| Tolmar, INC. | $233.86 | 2023-2025 | Jatenzo, Eligard |
| Myriad Genetic Laboratories, INC. | $231.61 | 2022-2024 | Prolaris |
| Urovant Sciences INC | $205.20 | 2021-2022 | |
| Accord Healthcare, INC. | $195.24 | 2022-2023 | |
| Janssen Biotech, INC. | $143.67 | 2019-2025 | Erleada |
| Tolmar Pharmaceuticals, INC. | $139.32 | 2019-2022 | |
| Pfizer INC. | $136.73 | 2019-2025 | |
| Amgen INC. | $125.64 | 2019-2020 | |
| Urogen Pharma, INC. | $105.86 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $101.34 | 2019-2025 | Adstiladrin |
| Coloplast Corp | $99.42 | 2021-2025 | |
| Neotract INC. | $87.74 | 2019-2020 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bernie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.